Taro Pharmaceutical Industries Ltd.
TARO · NYSE
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $362,909 | $154,495 | $251,134 | $605,177 |
| Short-Term Investments | $516,442 | $695,794 | $569,614 | $418,480 |
| Receivables | $177,463 | $241,802 | $292,479 | $252,861 |
| Inventory | $204,817 | $226,669 | $210,439 | $180,292 |
| Other Curr. Assets | $41,772 | $11,722 | $14,220 | $12,891 |
| Total Curr. Assets | $1,303,403 | $1,336,428 | $1,337,886 | $1,470,835 |
| Property Plant & Equip (Net) | $217,592 | $190,139 | $199,692 | $205,508 |
| Goodwill | $17,231 | $17,231 | $11,820 | $7,191 |
| Intangibles | $0 | $76,144 | $60,124 | $19,786 |
| Long-Term Investments | $457,991 | $404,896 | $435,189 | $557,209 |
| Tax Assets | $83,397 | $103,672 | $124,882 | $142,007 |
| Other NC Assets | $82,455 | $83,147 | $6,768 | $4,337 |
| Total NC Assets | $858,666 | $799,085 | $838,475 | $936,038 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,162,069 | $2,135,513 | $2,176,361 | $2,406,873 |
| Liabilities | – | – | – | – |
| Payables | $44,664 | $68,484 | $68,232 | $61,166 |
| Short-Term Debt | $0 | $1,950 | $2,204 | $1,689 |
| Tax Payable | $0 | $33,011 | $19,695 | $18,114 |
| Deferred Revenue | $0 | $903 | $5,788 | $7,583 |
| Other Curr. Liab. | $316,443 | $281,199 | $336,199 | $587,749 |
| Total Curr. Liab. | $361,107 | $385,549 | $432,119 | $676,301 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $616 | $919 | $1,095 |
| Deferred Tax Liab, NC | $0 | $19,106 | $32,799 | $35,115 |
| Other NC Liab. | $7,956 | -$616 | -$919 | -$1,095 |
| Total NC Liab. | $7,956 | $19,106 | $32,799 | $35,115 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $369,063 | $404,655 | $464,918 | $711,416 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,793,006 | $680 | $680 | $679 |
| Retained Earnings | $0 | $2,414,136 | $2,388,691 | $2,338,617 |
| AOCI | $0 | -$174,996 | -$168,965 | -$151,621 |
| Other Equity | $0 | -$508,961 | -$508,961 | -$484,027 |
| Total Equity | $1,793,006 | $1,730,858 | $1,711,443 | $1,703,649 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | -$8,192 |
| Total Liab. & Tot. Equity | $2,162,069 | $2,135,513 | $2,176,361 | $2,406,873 |
| Net Debt | -$362,909 | -$152,545 | -$248,930 | -$603,488 |